Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
5.28
-0.47 (-8.17%)
At close: Jun 5, 2026, 4:00 PM EDT
5.38
+0.10 (1.89%)
After-hours: Jun 5, 2026, 7:54 PM EDT
Turn Therapeutics Market Cap
Turn Therapeutics has a market cap or net worth of $157.28 million as of June 5, 2026.
Market Cap
157.28M
Enterprise Value
152.07M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.28
Market Cap Chart
Since October 8, 2025, Turn Therapeutics's market cap has decreased from $196.16M to $157.28M, a decrease of -19.82%. That is a compound annual growth rate of -28.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 157.28M | 35.57% |
| Dec 31, 2025 | 116.01M | -40.86% |
| Oct 8, 2025 | 196.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 175.50M |
| OnKure Therapeutics | 173.70M |
| Spero Therapeutics | 172.55M |
| Innate Pharma | 169.51M |
| ADC Therapeutics | 167.89M |
| Tenaya Therapeutics | 167.54M |
| Acumen Pharmaceuticals | 165.40M |
| Precision BioSciences | 165.39M |